newsfilter
← Latest News
GlobeNewswire·

Mersana Therapeutics to Host Third Quarter 2023 Conference Call on November 7, 2023

CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates